Emerging recombinant noroviruses identified by clinical and waste water screening
Abstract Norovirus is estimated to cause 677 million annual cases of gastroenteritis worldwide, resulting in 210,000 deaths. As viral gastroenteritis is generally self-limiting, clinical samples for epidemiological studies only partially represent circulating noroviruses in the population and is bia...
Main Authors: | Jennifer H. Lun, Joanne Hewitt, Alefiya Sitabkhan, John-Sebastian Eden, Daniel Enosi Tuipulotu, Natalie E. Netzler, Leigh Morrell, Juan Merif, Richard Jones, Bixing Huang, David Warrilow, Kelly-Anne Ressler, Mark J. Ferson, Dominic E. Dwyer, Jen Kok, William D. Rawlinson, Daniel Deere, Nicholas D. Crosbie, Peter A. White |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-03-01
|
Series: | Emerging Microbes and Infections |
Online Access: | http://link.springer.com/article/10.1038/s41426-018-0047-8 |
Similar Items
-
A Multi-Site Study of Norovirus Molecular Epidemiology in Australia and New Zealand, 2013-2014.
by: Kun Lee Lim, et al.
Published: (2016-01-01) -
RNA Sequencing of Murine Norovirus-Infected Cells Reveals Transcriptional Alteration of Genes Important to Viral Recognition and Antigen Presentation
by: Daniel Enosi Tuipulotu, et al.
Published: (2017-08-01) -
Recombinant GII.P16/GII.4 Sydney 2012 Was the Dominant Norovirus Identified in Australia and New Zealand in 2017
by: Jennifer H. Lun, et al.
Published: (2018-10-01) -
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase
by: Salvatore Ferla, et al.
Published: (2018-03-01) -
The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses
by: Daniel Enosi Tuipulotu, et al.
Published: (2019-05-01)